WO2013089636A1 - Processes for manufacturing of a kinase inhibitor - Google Patents

Processes for manufacturing of a kinase inhibitor Download PDF

Info

Publication number
WO2013089636A1
WO2013089636A1 PCT/SE2012/051411 SE2012051411W WO2013089636A1 WO 2013089636 A1 WO2013089636 A1 WO 2013089636A1 SE 2012051411 W SE2012051411 W SE 2012051411W WO 2013089636 A1 WO2013089636 A1 WO 2013089636A1
Authority
WO
Grant status
Application
Patent type
Prior art keywords
compound
formula
crystalline form
according
described
Prior art date
Application number
PCT/SE2012/051411
Other languages
English (en)
French (fr)
Inventor
Fredrik Lehmann
Ulf Bremberg
Ellen SÖLVER
BAJTNER Johan ERIKSSON
Oltner Viveca Thornqvist
Original Assignee
Akinion Pharmaceuticals Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
PCT/SE2012/051411 2011-12-15 2012-12-17 Processes for manufacturing of a kinase inhibitor WO2013089636A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US201161570866 true 2011-12-15 2011-12-15
US61/570,866 2011-12-15

Publications (1)

Publication Number Publication Date
WO2013089636A1 true true WO2013089636A1 (en) 2013-06-20

Family

ID=48612949

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE2012/051411 WO2013089636A1 (en) 2011-12-15 2012-12-17 Processes for manufacturing of a kinase inhibitor

Country Status (1)

Country Link
WO (1) WO2013089636A1 (ko)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060091067A1 (en) * 2004-11-02 2006-05-04 Agouron Pharmaceuticals, Inc. Methods for the removal of heavy metals
WO2009095399A2 (en) * 2008-02-01 2009-08-06 Akinion Pharmaceuticals Ab Pyrazine derivatives and their use as protein kinase inhbitors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060091067A1 (en) * 2004-11-02 2006-05-04 Agouron Pharmaceuticals, Inc. Methods for the removal of heavy metals
WO2009095399A2 (en) * 2008-02-01 2009-08-06 Akinion Pharmaceuticals Ab Pyrazine derivatives and their use as protein kinase inhbitors

Similar Documents

Publication Publication Date Title
WO2012071517A2 (en) Novel crystalline forms
WO2013024104A1 (en) 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2h-pyran-4-yl)-1 h-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor
US20120129865A1 (en) Crystalline (8s,9r)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1h-1,2,4-triazol-5-yl)-8,9-dihydro-2h-pyrido[4,3,2-de]phthalazin-3(7h)-one tosylate salt
WO2011071821A1 (en) Crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea and salts thereof.
CN101511829A (zh) 2-(吡啶-2-基氨基)-吡啶并[2,3-d]嘧啶-7-酮的合成
US20110021544A1 (en) Hydrochloride salt of ((1s,2s,4r)-4--2-hydroxycyclopentyl)methyl sulfamate
WO2008099944A1 (en) Crystalline forms of thiazolidinedione derivative and its manufacturing method
WO2011086541A1 (en) Novel polymorph of nilotinib monohydrochloride monohydrate
WO2003082857A2 (en) Lansoprazole polymorphs and processes for preparation thereof
CN1832949A (zh) 二肽基肽酶-iv抑制剂的磷酸盐
WO2012063933A1 (ja) 6,7-不飽和-7-カルバモイルモルヒナン誘導体の結晶およびその製造方法
WO2013069297A1 (ja) 7-{(3s、4s)-3-[(シクロプロピルアミノ)メチル]-4-フルオロピロリジン-1-イル}-6-フルオロ-1-(2-フルオロエチル)-8-メトキシ-4-オキソ-1、4-ジヒドロキノリン-3-カルボン酸の結晶
WO2011146511A1 (en) A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
WO2012082972A1 (en) Crystalline forms of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine
WO2012109423A1 (en) Method of inhibiting hamartoma tumor cells
WO2014118805A1 (en) Process for the preparation of ivacaftor and solvates thereof
WO2013053739A1 (en) Process for preparing factor xa inhibitors
WO2006048296A1 (en) Organic compounds
CN102260260A (zh) 8-苯基黄嘌呤类化合物、其制备方法、包含该化合物的药物组合物及其用途
WO2014173291A1 (zh) 氘代的二氨基嘧啶化合物以及包含该化合物的药物组合物
WO2005080381A1 (en) New polymorphic forms of ondansetron, processes for preparing them, pharmaceutical compositions containing them and their use as antiemetics
WO2011140328A1 (en) Saxagliptin intermediates, saxagliptin polymorphs, and processes for preparation thereof
CN103476770A (zh) 新的阿法替尼盐和多晶型物
WO2016127074A1 (en) 2-(pyridin-3-yl)-pyrimidine derivatives as ret inhibitors
CN104803908A (zh) 2-异丙氧基-5-甲基-4-(4-哌啶基)苯胺二盐酸盐的水合物、其制备方法及用途

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12857946

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct app. not ent. europ. phase

Ref document number: 12857946

Country of ref document: EP

Kind code of ref document: A1